Oakley Capital Origin Fund, managed by Oakley Capital Investments Limited (LSE:OCI) agreed to acquire an unknown majority stake in 7NXT Health GmbH from Crosslantic Fund I Gmbh & Co. Kg, managed by Crosslantic Capital Management GmbH and Markan Karajica for €42.6 million on August 7, 2020. As part of the transaction, Markan Karajica will continue in his role as chief executive officer and will retain a significant minority stake in the business. Gillian Martin of Liberum Capital Limited acted as financial advisor to Oakley Capital Investments Limited. Julian Riedlbauer of GP Bullhound acted as exclusive financial advisor to the shareholders of 7NXT Group and Crosslantic Capital Management GmbH in the transaction. Bub Memminger & Partner advised Crosslantic Capital as legal advisor and Stolzenberg Rechtsanwälte advised the 7NXT management team. Armand von Alberti, Marcel Maie, Alexander Euchne, Tobias Schupp and Timo Wagner of Ebner Stolz Mönning Bachem Wirtschaftsprüfer Steuerberater Rechtsanwälte, Financial Advisory Arm acted as financial advisors to Crosslantic Capital Management GmbH. Benjamin Leyendecker of Kirkland & Ellis International LLP acted as a legal advisor to Oakley Capital Investments Limited. Oakley Capital Origin Fund, managed by Oakley Capital Investments Limited (LSE:OCI) completed the acquisition of an unknown majority stake in 7NXT Health GmbH from Crosslantic Fund I Gmbh & Co. Kg, managed by Crosslantic Capital Management GmbH and Markan Karajica on October 1, 2020. Ernst & Young acted as accountant for Oakley Capital Origin Fund, managed by Oakley Capital Investments Limited.